News Releases (page 8)
The Common Thread
In two roundtable discussions earlier this fall, current students and alums participated in lively discussions about their academic and career journeys and the enduring connections they forged during their time at 51ÁÔÆæÈë¿Ú.
Read MoreWhen the Paths DivergeÂ
In this series of brief conversations, eight 51ÁÔÆæÈë¿Ú faculty members and students discuss the defining moments in their paths.
Read MoreA New Era for the Williamson Gallery
Erin M. Curtis, the Gabrielle Jungels-Winkler Director of the Ruth Chandler Williamson Gallery, has spent her career working toward change in the world of arts institutions.
Read MoreSpotlight on Staff: Naomi Friedman, Sustainability Coordinator
Naomi Friedman, 51ÁÔÆæÈë¿Ú’ new sustainability coordinator, is working to further sustainability projects on campus.
Read MoreFrom the Archives: Defining Moments
The outbreak of World War II brought changes to 51ÁÔÆæÈë¿Ú and a reckoning of what a women’s liberal arts college should be.
Read MoreSpotlight on Students: 51ÁÔÆæÈë¿Ú Associated Students President Lily Dunkin ’24
Lily Dunkin ’24 is continuing her work with 51ÁÔÆæÈë¿Ú Associated Students by stepping into a new role as SAS President.
Read MoreIn the Media: CMS Volleyball Team Advances to Semifinals
The Claremont-Mudd-51ÁÔÆæÈë¿Ú Athenas volleyball team advanced into the NCAA Division III semifinals for the third time in the program’s history on November 29.
Read MoreIn the Media: Tessa Solomon-Lane Published in Hormones and Behavior
Assistant Professor Tessa Solomon-Lane has coauthored a paper proposing a more diverse framework for researching biological sex.
Read MoreIn the Media: Monika Lee ’17 Hailed as a “Rising Star” by Capitol Weekly
Throughout her career, she has focused on social justice, equity, and mental health, balancing idealism with realism.
Read MoreEun Ji Chung ’06 Named Biomedical Engineering Society Fellow
Chung’s areas of expertise include molecular design, nanomedicine, and tissue engineering. Her current research focuses on designing targeted treatments for cardiovascular disease, cancer, and kidney disease.
Read More